Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kingshuk Panda

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Viruses|June 28, 2023
An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus InfectionKingshuk Panda, Deepti Parashar, Rajlakshmi Viswanathan
Molecules (Basel, Switzerland)|March 6, 2021
Oligonucleotide-Based Approaches to Inhibit Dengue Virus ReplicationKingshuk Panda, Kalichamy Alagarasu, Deepti Parashar
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 26, 2026
Molecular Clocks in Translational Roadmap for Circadian-Based Therapeutics in Lung DiseasesKingshuk Panda, Renu Khasa, Srinivasan Chinnapaiyan, et al.
International Journal of Molecular Sciences|June 10, 2023
Circadian-Coupled Genes Expression and Regulation in HIV-Associated Chronic Obstructive Pulmonary Disease (COPD) and Lung ComorbiditiesKingshuk Panda, Srinivasan Chinnapaiyan, Md Sohanur Rahman, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Anti-Dengue Activity of Lipophilic Fraction of <i>Ocimum basilicum</i> L. StemRajesh Kumar Joshi, Shivankar Agarwal, Poonam Patil, et al.
Frontiers in Immunology|May 4, 2026
scRNA sequencing revealed HIV-associated inflammation-mediated lung epithelial dysregulation and fibroblast remodelingKhursheed Ul Islam, Gagandeep Kaur, Sadiya Bi Shaikh, et al.
Viruses|September 28, 2024
RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?Kingshuk Panda, Kalichamy Alagarasu, Rajarshee Tagore, et al.
Molecular Therapy. Nucleic Acids|May 22, 2023
A conditional RNA Pol II mono-promoter drives HIV-inducible, CRISPR-mediated cyclin T1 suppression and HIV inhibitionSrinivasan Chinnapaiyan, Maria-Jose Santiago, Kingshuk Panda, et al.
Pharmaceutics|March 28, 2024
Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger ProblemsSuvankar Ghorai, Harshita Shand, Soumendu Patra, et al.
Molecules (Basel, Switzerland)|June 2, 2021
In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2)Kingshuk Panda, Kalichamy Alagarasu, Poonam Patil, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Viruses|June 28, 2023
An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus InfectionKingshuk Panda, Deepti Parashar, Rajlakshmi Viswanathan
Molecules (Basel, Switzerland)|March 6, 2021
Oligonucleotide-Based Approaches to Inhibit Dengue Virus ReplicationKingshuk Panda, Kalichamy Alagarasu, Deepti Parashar
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 26, 2026
Molecular Clocks in Translational Roadmap for Circadian-Based Therapeutics in Lung DiseasesKingshuk Panda, Renu Khasa, Srinivasan Chinnapaiyan, et al.
International Journal of Molecular Sciences|June 10, 2023
Circadian-Coupled Genes Expression and Regulation in HIV-Associated Chronic Obstructive Pulmonary Disease (COPD) and Lung ComorbiditiesKingshuk Panda, Srinivasan Chinnapaiyan, Md Sohanur Rahman, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Anti-Dengue Activity of Lipophilic Fraction of <i>Ocimum basilicum</i> L. StemRajesh Kumar Joshi, Shivankar Agarwal, Poonam Patil, et al.
Frontiers in Immunology|May 4, 2026
scRNA sequencing revealed HIV-associated inflammation-mediated lung epithelial dysregulation and fibroblast remodelingKhursheed Ul Islam, Gagandeep Kaur, Sadiya Bi Shaikh, et al.
Viruses|September 28, 2024
RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?Kingshuk Panda, Kalichamy Alagarasu, Rajarshee Tagore, et al.
Molecular Therapy. Nucleic Acids|May 22, 2023
A conditional RNA Pol II mono-promoter drives HIV-inducible, CRISPR-mediated cyclin T1 suppression and HIV inhibitionSrinivasan Chinnapaiyan, Maria-Jose Santiago, Kingshuk Panda, et al.
Pharmaceutics|March 28, 2024
Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger ProblemsSuvankar Ghorai, Harshita Shand, Soumendu Patra, et al.
Molecules (Basel, Switzerland)|June 2, 2021
In Vitro Antiviral Activity of α-Mangostin against Dengue Virus Serotype-2 (DENV-2)Kingshuk Panda, Kalichamy Alagarasu, Poonam Patil, et al.
Pageof 2